8-K//Current report
Quince Therapeutics, Inc. 8-K
Accession 0001193125-25-140873
$QNCXCIK 0001662774operating
Filed
Jun 12, 8:00 PM ET
Accepted
Jun 13, 5:25 PM ET
Size
827.5 KB
Accession
0001193125-25-140873
Documents
- 8-Kd31831d8k.htmPrimary
8-K
- EX-4.1d31831dex41.htm
EX-4.1
- EX-4.2d31831dex42.htm
EX-4.2
- EX-10.1d31831dex101.htm
EX-10.1
- EX-10.2d31831dex102.htm
EX-10.2
- EX-101.SCHqncx-20250612.xsd
XBRL TAXONOMY EXTENSION SCHEMA
- EX-101.LABqncx-20250612_lab.xml
XBRL TAXONOMY EXTENSION LABEL LINKBASE
- EX-101.PREqncx-20250612_pre.xml
XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
- XMLR1.htm
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001193125-25-140873-xbrl.zip
IDEA: XBRL DOCUMENT
- XMLd31831d8k_htm.xml
IDEA: XBRL DOCUMENT
Issuer
Quince Therapeutics, Inc.
CIK 0001662774
Entity typeoperating
IncorporatedCA
Related Parties
1- filerCIK 0001662774
Filing Metadata
- Form type
- 8-K
- Filed
- Jun 12, 8:00 PM ET
- Accepted
- Jun 13, 5:25 PM ET
- Size
- 827.5 KB